NCT02819115

Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine

Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 63 (actual)
• Sponsor: Butantan Institute · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Prospective study to evaluate the safety and immunogenicity of Butantan Influenza seasonal vaccine.

Detailed description

Prospective cohort study to evaluate safety (three days post vaccination) and immunogenicity (measured 21 days post vaccination) of one dose of Butantan Influenza vaccine.

Conditions

• Influenza

Interventions

Type	Name	Description
BIOLOGICAL	Butantan Fragmented Inactivated Trivalent Influenza Vaccine	Butantan Fragmented Inactivated Trivalent Influenza Vaccine

Timeline

• Start date: 2013-06-01
• Primary completion: 2013-07-01
• Completion: 2013-07-01
• First posted: 2016-06-30
• Last updated: 2016-06-30

Locations

2 sites across 1 country: Brazil